DurvalumabFulminant myositis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2030卷 / 1期

关键词：

D O I：

10.1007/s40278-024-68976-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：175 / 175

相关论文

共 50 条

[1] DurvalumabFulminant type 1 diabetes mellitus: case report
Reactions Weekly, 2022, 1929 (1) : 269 - 269
[2] VoriconazoleFirst report of myositis: case report
Reactions Weekly, 2010, 1283 (1) : 90 - 90
[3] TacrolimusFirst report of myositis: case report
Reactions Weekly, 2004, 1011 (1) : 14 - 14
[4] SorafenibFirst report of myositis: case report
Reactions Weekly, 2011, 1346 (1) : 37 - 37
[5] VenlafaxineFirst report of myositis: case report
Reactions Weekly, 2005, 1040 (1) : 18 - 18
[6] PembrolizumabOcular myositis: case report
Reactions Weekly, 2020, 1820 (1) : 262 - 262
[7] GemcitabineToxic myositis: case report
Reactions Weekly, 2010, 1300 (1) : 24 - 24
[8] BortezomibInflammatory myositis : case report
Reactions Weekly, 2022, 1911 (1) : 105 - 105
[9] PembrolizumabRhabdomyolysis and myositis: case report
Reactions Weekly, 2018, 1707 (1) : 224 - 224
[10] GemcitabineRadiation myositis: case report
Reactions Weekly, 2001, 843 (1) : 8 - 8

← 1 2 3 4 5 →